Member Info for PM2022

I guess Suzy, George and Satu all knew each other and had links with each other but I suspect Suzy is not the type. I think Kevin and Suzy are trustworthy but at a loss what hell is going on with 201.

Patience for me until end of September then I will reconsider my investment. Still believe but if no update at least in the next month or two then I will likely sell my few 100k shares or reduce position as I am not understanding why it would take so much longer if they really had interest.

She keepings getting questions due to a lack of information coming through an RNS and people are questioning what is going on.

Appreciate with a pharmaceutical company things take time but we seem to get nothing other than an RNS regarding clinical results. No real updates through RNS like other AIM companies every 3-6 months or maybe slightly longer or whatever is reasonable but nothing in such a long time with so much going on is a disappointment.

I once read an RNS that a company once had numerous offers and an RNS was released to say that one will be picked in the near future and although the share price went up at least it was an update.

Does any know the timeframe for the preclinical experimental data to be completed for BC201 and when exactly it started?

I am guessing it would take months rather than years to get the data for this so perhaps an update?

Probably both but mainly 201 and 301 as that is the key priority. Otherwise who would fund new projects when you have 3 parked drugs.

Maybe she has some important meetings at the end of this month before closing deals or is signing one.

Would be good to get the news out next week.

If you watched the live Q and A and read the monthly Q and A's it does appear that they are very confident. Also if they cannot get a deal then what was the point of doing all the work with Physiomics and why would Physiomics get involved in such a deal.

The Japanese would also have to pull out for complete failure so everything would have to fail for the market cap to go down long term.

Given our market cap pretty much any deal should see us move anywhere from 30p to 250p within days. Problem is how long they take and the complete lack of update and news through an RNS for such a long time.

August/September we would think but then again all my predictions have been wrong and we could be saying the same thing in many months time.

Val are terrible at getting things done within a decent time but I hope I am wrong. A great entry price at the moment as at some point should come good.

Great response by Adam.

Suzy please copy and paste and take out the number of interested parties the rest will do. Please send out an RNS soon it's been almost a year since any real update even if we waiting on a deal.

What a negative response.

Hopefully Suzy can give us a bit more information.

Good lad. Make sure you sell some at the highs and enjoy it. I'm sure you deserve it after all these years.

If nothing goes wrong that is, we can only hope.

The real art of making real money buy very low when people are fearful and sell very high. History proves this.

This market cap is insane at the moment and who has the guts to take advantage here.. We will look back at these moments. All in at the moment and looking forward to the next few weeks.

Imagine a deal like this. 625 million upfront payment. Goes to show our market cap of 11 million is very low and we have 2 phase 2 proven drugs and a very promising preclinical drug. Although it is completely different big money paid for some early stage drugs and nothing beats the need for a cure for endometriosis.

It is not wonder why PYC signed a 6 per cent deal with Val. 18p is a steal at the moment.

https://www.evaluate.com/vantage/articles/news/snippets/glaxo-pays-handsomely-join-tigit-chase

Would make sense to try and close a deal for 201 so when they negotiate a deal with the Japanese for 301 the company will be worth far more and we may not seem so desperate and will be able to negotiate a better deal.

The time they are taking is not helping the share price and therefore potentially the value of these drugs to potential partners. Looking forward to the next Q and A to see what they say this time.

Watch this space.

Such a low market cap. Any decent news which is expected very soon will rocket this share price. Refer to all the Q and A for confirmation. PYC also expect a nice pay cheque after some great work which is ongoing and they know it with the addition of extra technical staff as well.

This should add value just before a big deal for 201 in announced. The sign of things to come in the following days/weeks.

It's my take on the situation. Read the recent Q and A it will give you a strong hint but obviously they cannot tell us anything unless we get an RNS so just have to read between the lines.

No RNS until confirmation of financials and timelines. Seems clear it will be a JV if no offers then they would not know that. These things take time and require definite confirmation as stated in Q and A before they let the market know. I think we will get the news very soon.

Another spiker talking rubbish.

If they get a deal they should get upfront payments. Also a dilution of few million at a much higher share price if at all needed will not be a significant dilution. If no deal and dilution at this price then I agree. But a deal is highly likely and based on Q and A and by reading between the lines they have deals and have accepted one already.

Expect news in the next 2 weeks for me.

Deal can come anytime. Analysis of 201 done.

At the current time, Physiomics have carried out analysis on the clinical data, and when the new
preclinical data being generated for the endometriosis project (detailed above) and for BC201 (detailed
below) are available, they will continue to amalgamate these new data points into their models.

News to drop next week regarding 201 remains a strong possibility for me.

Will be adding more today.

Most of that work is relating to 301 and BC201 although it helps with some aspects of 201.

Valirx have been sharing data with potential with partners for the last few months and by now they should have had offers. Expecting news in the next week or two regarding 201.

As many people have said 201 is a priority and they will not wait until that date but you can if you wish.